Antibody Engineering and Therapeutics is the #1 forum for scientific exchange and networking in the fields of antibody engineering and therapeutics, immunobiology and next-generation binders. For over 25 years, renowned academic and industry scientists from around the world have convened to share best practices and scientific results to accelerate antibody research, discovery efforts and clinical programs. With 900+ attendees, 135+ speaker presentations and 75+ exhibitors and 135+ scientific posters focused on antibody science and technology. For more information or to register, visit: www.AntibodyEng.com. URL: Tickets: https://go.evvnt.com/250507-1?pid=5569 Prices:Industry Rate for 4-Day Conference: USD 2699.0,Academic/Government Rate for 4-Day Conference: USD 1099.0,Industry Rate for Full-Day Pre-Conference Workshop: USD 899.0,Government/Academic Rate for Full-Day Pre-Conference Workshop: USD 599.0,Industry Rate for Half-Day Pre-Conference Workshop: USD 499.0,Academic Rate for Half-Day Pre-Conference Workshop: USD 299.0. Speakers: Rachael Clark, MD, PhD Shing-Yiu Yip and Cecilia M. Hepp Associate Professor of Dermatology at Harvard Medical School, Bahija Jallal, PhD President, Medimmune and Executive Vice President, AstraZeneca at Medimmune and AstraZeneca, David Baker, PhD Professor of Biochemistry at University of Washington, Sally Ward, PhD Professor, Department of Molecular and Cellular Medicine at Texas AandM University Health Science Centre and Centre for Cancer Immunology and University of Southampton. Time: 8:00 am to 5:00 pm. Venue details: Manchester Grand Hyatt San Diego, 1 Market Place, San Diego, 92101, United States.